Issuer Information

EDGAR: Contact Information
  • Name:
    Aadi Bioscience, Inc.
  • Address:
    2 HEADQUARTERS PLAZA
    EAST BUILDING, 11TH FLOOR

    MORRISTOWN, NEW JERSEY 07960
  • Phone:
    551-321-2234
EDGAR: Other Information
  • Jurisdiction:
    DELAWARE
  • Entity Type:
    Corporation
  • Incorporated:
    Over 5 years ago
  • Previous Names:
    Aerpio Pharmaceuticals, Inc.
    ZETA ACQUISITION CORP II

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
550185: 0002018445-25-000002
First Sale: 2025-03-04
Security Type(s): Equity
Offer Amount: $100,002,392
Amount Sold: $100,002,392
06b

CA, NJ, NY, TX,

461891: 0001209191-22-053234
First Sale: 2022-09-26
Security Type(s): Equity
Offer Amount: $72,500,000
Amount Sold: $72,499,995
Remaining: $5
06b

CA, NJ, NY,

389228: 0001209191-21-055406
First Sale: 2021-08-26
Security Type(s): Equity
Offer Amount: $155,000,000
Amount Sold: $154,999,876
Remaining: $124
06b

CA, CT, MD, PA,

389217: 0001209191-21-055401
First Sale: 2021-08-26
Security Type(s): Equity
Offer Amount: $82,500,000
Amount Sold: $82,500,000
06b

CA, NJ,

235378: 0001422142-17-000002
First Sale: 2017-03-15
Security Type(s): Equity
Offer Amount: $41,835,597
Amount Sold: $41,835,597
06b

CA, IL, IN, KS, MD, ME, MI, MN, MO, NJ, NV, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, VT, WA, WI, WY,

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.